Key Insights

Highlights

Treatment Research

2 treatments under study, led by Gonadotropins Plus Dhea

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2/3 (1)

Trial Status

Unknown1

Clinical Trials (1)

Research Network

Common Treatments

  • Gonadotropins Plus Dhea1
  • Gonadotropins1

Active Sponsors

  • Lito Maternity Hospital1
  • University of Athens1

Top Investigators

Related Conditions

  • Changes In Amh1
  • Diminished Ovarian Reserve1
  • Pregnancy Rate1

Activity Timeline